Michael Wakelam - Curriculum Vitae#

Obituary, Barbraham Institute

  • B.Sc. (Hons) Medical Biochemistry, Birmingham University, 1977
  • Ph.D. Biochemistry, Birmingham University, 1980
  • Director and Chief Executive of the Babraham Institute (since 1.1.2017)
  • Honorary Professor of Lipid Signalling, Cambridge University
  • Honorary Professor of Cell Signalling, Birmingham University
  • Visiting Professor Kings College London

Previous posts:
  • Professor of Molecular Pharmacology, Cancer Studies, Birmingham University, 1993-2016
  • Lecturer, Senior Lecturer, Reader, Biochemistry Department, Glasgow University, 1985-1993
  • Awards: Morton Lecturer, Biochemical Society 2018

Publications: 165 research papers, 55 reviews, book chapters; >13900 citations, H factor = 62

Grant funding during the past 10 years
  • BBSRC funding for the Babraham Institute 2017-2022 £10.95M pa.
  • Wellcome Trust Biomedical Resources Grant “LIPID MAPS Resource and Database” with O’Donnell (Cardiff), Dennis (UCSD, USA), £1,362,256, 2016-2021
  • EU Horizon 2020 “Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities (HEP-CAR).” €5.8M, €0.6M to Babraham. 2016-2021
  • BBSRC funding for the Babraham Institute 2012-2017 £12.451M pa.
  • Medical Research Council project grant with Le Novere, Solari and Edwards (Imperial College) “Modification of the host lipidome by Rhinovirus infection” £563,368, 2015-2018
  • BBSRC Brazil Partnering Award “Influence of gut microbiota derived short chain fatty acids on intestinal maturity” £74,500 2014-2018
  • CRUK/AstraZeneca with Gottlieb (Beatson Inst), Schulze (LRI), Harris (Oxford University), Aboagye (Imperial) “Targetting lipid metabolism for cancer therapy.” £600,000; £115,000 to Babraham 2011-2013.
  • BBSRC grant with Hawkins and Clark “The synthesis of tools for the quantification by mass spectroscometry of biologically relevant phosphatidylinositol phosphates.” £150,490 2010-2011
  • MRC Programme grant “The physiological importance of phospholipase D signalling” £1,536,065 2009-2016
  • EU FP7 Large scale Integrating Project “High throughput analysis of lipid and lipid-protein interactions” 2008-2012 €11,603930; €413,727 to Babraham
  • CRUK with Parker, Larijani, Woscholski, Tooze “Programme in Lipidomic Oncology” 2006-2010 £1,100,000

Imprint Privacy policy « This page (revision-5) was last changed on Monday, 4. May 2020, 11:37 by Kaiser Dana
  • operated by